New York State Common Retirement Fund’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
26,200
+24,972
| +2,034% | +$1.21M | ﹤0.01% | 1578 |
|
|
2025
Q1 | $42K | Hold |
1,228
| – | – | ﹤0.01% | 2833 |
|
|
2024
Q4 | $48K | Hold |
1,228
| – | – | ﹤0.01% | 2866 |
|
|
2024
Q3 | $58K | Hold |
1,228
| – | – | ﹤0.01% | 2810 |
|
|
2024
Q2 | $66K | Hold |
1,228
| – | – | ﹤0.01% | 3015 |
|
|
2024
Q1 | $84K | Hold |
1,228
| – | – | ﹤0.01% | 2812 |
|
|
2023
Q4 | $77K | Buy |
+1,228
| New | +$77K | ﹤0.01% | 2842 |
|
|
2022
Q2 | – | Sell |
-5,934
| Closed | -$372K | – | 3484 |
|
|
2022
Q1 | $372K | Buy |
5,934
+2,000
| +51% | +$125K | ﹤0.01% | 2536 |
|
|
2021
Q4 | $298K | Buy |
3,934
+150
| +4% | +$11.4K | ﹤0.01% | 2711 |
|
|
2021
Q3 | $424K | Hold |
3,784
| – | – | ﹤0.01% | 2551 |
|
|
2021
Q2 | $613K | Sell |
3,784
-1,050
| -22% | -$170K | ﹤0.01% | 2486 |
|
|
2021
Q1 | $589K | Sell |
4,834
-3,010
| -38% | -$367K | ﹤0.01% | 2373 |
|
|
2020
Q4 | $1.2M | Buy |
7,844
+5,210
| +198% | +$798K | ﹤0.01% | 1959 |
|
|
2020
Q3 | $220K | Hold |
2,634
| – | – | ﹤0.01% | 2604 |
|
|
2020
Q2 | $194K | Hold |
2,634
| – | – | ﹤0.01% | 2653 |
|
|
2020
Q1 | $112K | Sell |
2,634
-3,011
| -53% | -$128K | ﹤0.01% | 2715 |
|
|
2019
Q4 | $344K | Buy |
5,645
+3,061
| +118% | +$187K | ﹤0.01% | 2470 |
|
|
2019
Q3 | $106K | Buy |
2,584
+450
| +21% | +$18.5K | ﹤0.01% | 3012 |
|
|
2019
Q2 | $101K | Sell |
2,134
-200
| -9% | -$9.47K | ﹤0.01% | 3102 |
|
|
2019
Q1 | $83K | Sell |
2,334
-150
| -6% | -$5.33K | ﹤0.01% | 2997 |
|
|
2018
Q4 | $71K | Sell |
2,484
-4,619
| -65% | -$132K | ﹤0.01% | 3043 |
|
|
2018
Q3 | $315K | Sell |
7,103
-2,488
| -26% | -$110K | ﹤0.01% | 2628 |
|
|
2018
Q2 | $564K | Sell |
9,591
-100
| -1% | -$5.88K | ﹤0.01% | 2398 |
|
|
2018
Q1 | $443K | Buy |
9,691
+1,107
| +13% | +$50.6K | ﹤0.01% | 2409 |
|
|
2017
Q4 | $202K | Sell |
8,584
-10,692
| -55% | -$252K | ﹤0.01% | 2754 |
|
|
2017
Q3 | $344K | Buy |
+19,276
| New | +$344K | ﹤0.01% | 2536 |
|